Assessing biological and technological variability in protein levels measured in pre-diagnostic plasma samples of women with breast cancer
暂无分享,去创建一个
[1] P. Forget,et al. A Timely Shift from Shotgun to Targeted Proteomics and How It Can Be Groundbreaking for Cancer Research , 2017, Front. Oncol..
[2] Bruno Manadas,et al. SWATH‐MS as a tool for biomarker discovery: From basic research to clinical applications , 2017, Proteomics.
[3] Hendrik Koffijberg,et al. Detecting Blood-Based Biomarkers in Metastatic Breast Cancer: A Systematic Review of Their Current Status and Clinical Utility , 2017, International journal of molecular sciences.
[4] John F. Timms,et al. Serial Patterns of Ovarian Cancer Biomarkers in a Prediagnosis Longitudinal Dataset , 2015, BioMed research international.
[5] Ruedi Aebersold,et al. Quantitative variability of 342 plasma proteins in a human twin population , 2015 .
[6] Ulf Gyllensten,et al. Strong effects of genetic and lifestyle factors on biomarker variation and use of personalized cutoffs , 2014, Nature Communications.
[7] J. Stenvang,et al. Homogenous 96-Plex PEA Immunoassay Exhibiting High Sensitivity, Specificity, and Excellent Scalability , 2014, PloS one.
[8] H. Langen,et al. Antibody‐based proteomics and biomarker research—Current status and limitations , 2014, Proteomics.
[9] S. Pitteri,et al. Performance evaluation of affinity ligands for depletion of abundant plasma proteins. , 2013, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[10] Olga Vitek,et al. A statistical model-building perspective to identification of MS/MS spectra with PeptideProphet , 2012, BMC Bioinformatics.
[11] J. Pennings,et al. A Bead-Based Multiplexed Immunoassay to Evaluate Breast Cancer Biomarkers for Early Detection in Pre-Diagnostic Serum , 2012, International journal of molecular sciences.
[12] S. Hanash,et al. Concordant release of glycolysis proteins into the plasma preceding a diagnosis of ER+ breast cancer. , 2012, Cancer research.
[13] Diederick E Grobbee,et al. Searching for early breast cancer biomarkers by serum protein profiling of pre-diagnostic serum; a nested case-control study , 2011, BMC Cancer.
[14] R. Aebersold,et al. A High-Confidence Human Plasma Proteome Reference Set with Estimated Concentrations in PeptideAtlas* , 2011, Molecular & Cellular Proteomics.
[15] Jacob Kennedy,et al. Detection of elevated plasma levels of epidermal growth factor receptor before breast cancer diagnosis among hormone therapy users. , 2010, Cancer research.
[16] S. Hanash,et al. Confounding Effects of Hormone Replacement Therapy in Protein Biomarker Studies , 2010, Cancer Epidemiology, Biomarkers & Prevention.
[17] Gary Goodman,et al. Assessing Lead Time of Selected Ovarian Cancer Biomarkers: A Nested Case–Control Study , 2010, Journal of the National Cancer Institute.
[18] J. Manson,et al. Postmenopausal estrogen and progestin effects on the serum proteome , 2009, Genome Medicine.
[19] David C Muddiman,et al. Mass spectrometry-based biomarker discovery: toward a global proteome index of individuality. , 2009, Annual review of analytical chemistry.
[20] Jacob J. Kennedy,et al. Application of serum proteomics to the Women's Health Initiative conjugated equine estrogens trial reveals a multitude of effects relevant to clinical findings , 2009, Genome Medicine.
[21] Veronika A. Glukhova,et al. Quantitative analysis of acrylamide labeled serum proteins by LC-MS/MS. , 2006, Journal of proteome research.
[22] Norman Boyd,et al. The Breast Cancer Family Registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer , 2004, Breast Cancer Research.